Teva Pharmaceutical Industries Limited (TEVA) Presents at U.S. All Stars Conference Transcript

Teva Pharmaceutical Industries Limited ( TEVA ) U.S. All Stars Conference September 22, 2026 3:00 AM EDT Company Participants Richard Francis - President, CEO & Director Conference Call Participants Christopher Schott - JPMorgan Chase & Co, Research Division Presentation Christopher Schott JPMorgan Chase & Co, Research Division Thank you, everyone, for joining us. Again, I'm Chris Schott from JPMorgan, and it's my pleasure to be hosting this conversation with Richard Francis, CEO of Teva. It's obviously been a really amazing story the last few years as you've transformed the company. Question-and-Answer Session Christopher Schott JPMorgan Chase & Co, Research Division So we're going to just kick off some bigger picture questions, and then we'll dig into some details on the product portfolio pipeline, and we'll leave a few minutes for questions at the end. So with that, Richard, maybe just a bigger picture question. I think you're coming up on your fourth year as CEO of Teva. There's obviously been a lot of progress across the portfolio. Can you talk about the biggest changes you've seen at the organization as you've kind of transformed the company and just how you think about the positioning of the company going forward? Richard Francis President, CEO & Director Well, firstly, thanks, Chris, for hosting. I appreciate it and giving the early session in. That's a pretty -- that's a question we could spend 45 minutes talking about, but I'll try to make it as succinct as possible. And I think if I just make some sort of simple headlines is, so when we started this -- and probably the reason you didn't cover us back then was we are a pure-play generics company, and you probably had big question marks as well. And with Pivot, we said we're going to become a world-class biopharma company. Now that seemed like a hard leap of faith for anybody to believe. But when you think